We have previously shown that an exogenous type I collagen matrix can regulate expression of mRNA for parathyroid hormone (PTH)-related protein (PTHrP) and its receptor, the PTH/PTHrP receptor, in the UMR106-06 osteogenic sarcoma cell line, which is considered to be representative of a relatively mature osteoblast phenotype. Consistent with those data, we show here that growth of UMR106-06 cells on type I collagen increased PTH/ PTHrP receptor-binding capacity. Analysis of the binding data showed that the number of PTH/PTHrP receptors expressed by cells cultured on collagen was at least 2-fold greater than that of cells cultured on plastic.
Introduction
The importance of cell adhesion for normal cell function has now been well demonstrated in a number of systems (Adams & Watt 1993) . In bone, where the extracellular matrix (ECM) comprises approximately 85% type I collagen (Eyer 1980) , cellular interaction with matrix components has been shown to be important in both osteoclastic activity (Shankar et al. 1993) and regulation of the osteoblast phenotype (Andrianarivo et al. 1992 , Traianedes et al. 1993 . For example, we have previously shown that plating of preosteoblastic cells on type I collagen promotes osteoblastic differentiation (Traianedes et al. 1993) . More recently, we have shown in a model of the mature osteoblast, UMR106-06 cells, that a type I collagen substrate increases the expression of mRNA for the parathyroid hormone (PTH)-related protein (PTHrP) and its receptor, the PTH/PTHrP receptor (Celic et al. 1996) as well as the response of cells to PTH stimulation, reflected by changes in PTH-induced cAMP accumulation (Celic et al. 1996) . This result was consistent with the demonstrated increase in expression of this receptor as a function of osteoblast maturation (Suda et al. 1995 , Bos et al. 1996 .
The mechanism(s) by which ECM molecules regulate gene expression is not well understood, although a number of well characterized cell surface adhesion molecules are clearly involved (Hynes 1992) . In particular, members of the integrin family of receptors have been shown to mediate many of the effects of collagen, fibronectin and other ECM molecules. Upon activation of these receptors by ECM ligand binding, receptor clustering occurs and the formation of focal adhesions (Turner & Burridge 1991) . This aggregation of receptors leads to a number of intracellular responses such as the alteration of intracellular pH, calcium levels, protein phosphorylation states, generation of arachidonic acid metabolites and re-arrangement of the cytoskeleton (Hynes 1992) . Integrin-mediated regulation of gene expression appears to involve modulation of several protein kinases, including tyrosine kinases, although these events are clearly cell specific (Kornberg et al. 1991 , Schwartz et al. 1995 .
The present study was designed to extend our earlier observations on matrix modulation of the PTH/PTHrP receptor mRNA in UMR106-06 cells (Celic et al. 1996) . Using ligand-binding studies, we have shown that culture of UMR106-06 cells on a type I collagen substrate upregulates the cell surface expression of the PTH/PTHrP receptor, which is antagonized by retinoic acid (RA) treatment. Growth of these cells on collagen produced changes in the expression of alkaline phosphatase (ALP) and osteopontin (OP) mRNA, as seen previously in the preosteoblastic cell line, UMR201 (Traianedes et al. 1993) . Experiments were performed to elucidate the intracellular and extracellular mechanisms by which collagen exerted these effects, the latter using approaches aimed at perturbing the presumed basis of these effects, the collagen-integrin receptor interaction. The results suggest that a direct interaction between UMR106-06 cells and the collagen proteins produced the collagen-mediated effects on osteoblastic gene expression, by a mechanism that is likely to involve protein tyrosine kinase activity.
Materials and Methods

Cell culture
The rat osteosarcoma osteoblast-like cell line UMR106-06 (Forrest et al. 1985) was cultured in Eagle's minimum essential medium (MEM; Gibco Laboratories, Grand Island, NY, USA) containing 10% foetal bovine serum (Cytosystems, Castle Hill, NSW, Australia). All media contained gentamicin (80 mg/l; DBL, Mulgrave, Victoria, Australia), minocycline (1 mg/ml; Sigma Chemical Co., St Louis, MO, USA) and Hepes (16 mM; Gibco Laboratories). Cells were incubated at 37 C and equilibrated with 5% CO 2 in humidified air. Cells were used between passages 10 and 30. Trypsin-EDTA was used for harvesting cells on plastic.
Type I collagen gels
Cells were grown directly on plastic cell culture dishes or on a thin layer of gelled rat tail type I collagen (Collaborative Research, Waltham, MA, USA). The collagen was diluted in MEM to a stock concentration which would result in a gel of 25 µg/cm 2 when 1 ml was used to coat 58 cm 2 petri dishes, for RNA harvests, or 200 µl for 3·8 cm 2 wells, for binding experiments. The collagen gels were allowed to set at room temperature prior to incubation at 37 C overnight. Glycation of collagen (AGE collagen) was achieved by incubating unmodified collagen gels of 50 µg/cm 2 with 0·5 M glucose-6-phosphate for 0, 1 or 3 weeks to generate collagen substrates with increasing glycation levels, as previously described (Katayama et al. 1996) . AGE modification of collagen was quantified by measuring AGEspecific fluorescence emission spectra at 370 nm excitation wavelength and 440 nm emission wavelength, using a fluorimeter (F-850, Hitachi Industrial Co. Ltd, Tokyo, Japan). Collagen-coated dishes after 0, 1 or 3 weeks glycation contained 0, 16·2 and 31·2 relative fluorescence units/mg protein respectively. Cells were cultured onto plastic, control unmodified collagen (50 µg/cm 2 for AGE collagen experiments) or AGE collagen, for 24 h prior to total RNA harvest for analysis by Northern blot or cell harvest for counting. Prior to RNA harvest or cell counting, collagen gels were dissolved using 1 mg/ml collagenase (Worthington Biochemical Corp., Freehold, NJ, USA) in PBS at 37 C for 20 min.
Inhibitors and peptides
Cells were subcultured onto plastic or a 25 µg/cm 2 type I collagen gel, in 58 cm 2 dishes in the presence or absence of inhibitors or activators of signal transduction pathways or peptides that mimic putative cell-binding domains in collagen. After 24 h incubation, total RNA was harvested and analysed by Northern blot. Substances were: herbimycin A, genistein (4 ,5,7-trihydroxyisoflavone), chelrythrine chloride, calphostin C, microcystin-LR, H-7, U-73122, tautomycin, calyculin A, okadaic acid (potassium salt) and phorbol 12-myristate 13-acetate (PMA), thapsigargin and indomethacin (purchased from BIOMOL Research Laboratories, Plymouth Meeting, PA, USA), sodium metavanadate (Sigma Chemical Co.). GRGDTP and GRGESP peptides were purchased from Life Technologies Pty Ltd (Grand Island, NY, USA) and DGEA and KDGE peptides were custom synthesized from Auspep Pty Ltd (Parkville, Australia).
Northern blot analysis
Total cellular RNA was extracted from cells in 58 cm 2 petri dishes using guanidinium thiocyanate (Chomczynski & Sacchi 1987) . Twenty micrograms of each sample of RNA were electrophoresed through a 1·2% (w/v) formaldehyde gel and transferred to nylon filter (Hybond N+, Amersham International, Amersham, Bucks, UK or Magna nylon transfer membrane, Micron Separations Inc., Westboro, MA, USA) (Sambrook et al. 1989) . Filters were hybridized with 32 P-dATP labelled (by random priming) fragments: R15b fragment of rat PTH/PTHrP receptor cDNA (Abou-Samra et al. 1992) , rat OP (Yoon et al. 1987) , rat ALP (Noda & Rodan 1987) or, for loading standardization, human liver glyceraldehyde-3-phosphate (GAPDH) cDNA (Arcari et al. 1984) . The filters were exposed to a phosphor screen and the signal quantified using a PhosphorImager SF (Molecular Dynamics, Sunnyvale, CA, USA) and the computer analysis program ImageQuant (Molecular Dynamics). (Goldman et al. 1988) . The reaction mixture was purified using a C18 SepPak column, as described previously (Goldman et al. 1988) , and stored at 20 C. 
I labelling of PTH
Binding studies
Binding analysis and statistics
Four saturation binding experiments, each with samples in triplicate, were used for analysis. Binding data were analysed by the iterative curve-fitting program LIGAND (Munson & Rodbard 1980) as adapted by McPherson (1985) . Statistical significance of changes in binding parameters were assessed using a Student's t-test, following logarithmic transformation of parameters and P values of <0·05 were regarded as significant.
Results
Effect of collagen on PTH/PTHrP receptor-binding capacity
We have previously shown that in UMR106-06 cells grown on a type I collagen substrate, PTH/PTHrP receptor mRNA levels were increased, and cAMP accumulation in response to PTH was enhanced, compared with cells grown on tissue culture plastic (Celic et al. 1996) . Since these results suggested increased cell surface PTH/PTHrP receptor expression, we sought to confirm this by measuring receptor-binding directly. When the PTH analogue 125 I- [Nle 8, 18 ,Tyr 34 ]bPTH (1-34) NH 2 was used as radioactive ligand, a marked increase in specific binding was seen in cells cultured on collagen compared with cells grown on plastic, whether experiments were performed at room temperature ( Fig. 1 ), 4 C (data not shown), or at 37 C (data not shown). Saturation binding studies were performed to determine cell surface receptor number and ligand affinity. Analysis of the binding data indicated that the radioligand bound to a single population of high-affinity binding sites. In cells grown on collagen, PTH/PTHrP receptor number was approximately 2-fold greater than in cells grown on plastic (Table 1 ). The increased binding was not due to increased ligand affinity for the receptor site; the dissociation constant for the ligand-receptor interaction was in fact slightly higher with cells grown on collagen than cells grown on plastic. RA treatment of the cells grown on either substrate significantly decreased the number of ligand-binding sites compared with the respective untreated controls.
Collagen effect on mRNA expression of OP and ALP
There is now good evidence that expression of the PTH/PTHrP receptor increases as a function of osteoblast differentiation (McCauley et al. 1995 , Suda et al. 1995 , Bos et al. 1996 . We therefore examined the expression of two other osteoblast-associated gene products, OP and ALP, in response to culturing of UMR106-06 cells on collagen. It was observed that growing the cells on collagen for 24 h increased the steady-state levels of both OP mRNA and ALP mRNA approximately 2-fold, compared with cells grown on plastic (Fig. 2 ). Treatment with RA had an effect on the expression of ALP mRNA (Fig. 2B ) similar to that on PTH/PTHrP receptor mRNA, decreasing mRNA levels on both substrates and abrogating the effect of collagen. However, RA treatment increased the expression of OP mRNA on plastic approximately 2-fold and synergized with collagen to cause superinduction of approximately 8-fold, compared with control cells on plastic (Fig. 2C) . The time course of these events was studied and these results are shown in Fig. 3 . The temporal effects of collagen were different for the three mRNA species. In addition, RA treatment enhanced, in the case of OP mRNA, or inhibited, in the case of ALP and PTH/PTHrP receptor mRNA, the effects of collagen at each of the times studied. 
Investigation of cellular interaction with collagen
Experiments were designed to investigate the nature and importance of cellular interaction with type I collagen for the collagen-induced effects described above. First, we tested the effect of covalent modification of type I collagen by non-enzymatic glycation. Culture of UMR106-06 cells on AGE collagen reduced or abolished the increase in PTH/PTHrP receptor mRNA (Fig. 4D ) and OP mRNA (Fig. 4C ) levels seen in cells on unmodified type I collagen. However, ALP mRNA expression, which is also increased in cells cultured on control collagen, remained increased when cells were cultured on AGE collagen at several levels of glycation (Fig. 4B) . The ability of the cells to adhere to AGE collagen was not different from unmodified collagen. Secondly, cells were plated onto collagen in the presence of peptides that represent putative cell-binding domains in collagen. The peptide GRGDTP was used to determine whether attachment at the RGD amino acids site in collagen might mediate the collagen-induced effects in UMR106-06 osteoblast-like cells. The peptide GRGESP was used as a negative control. Peptide concentrations ranging from 0·01 µM to 1·0 mM did not alter cell attachment (not shown) or mRNA steady-state levels of the PTH/PTHrP receptor, OP and ALP in cells cultured Figure 2 Effect of plating UMR106-06 cells on a type I collagen substrate on the expression of OP and ALP mRNA. Cells were plated onto plastic or a type I collagen gel in the presence or absence of 10 6 M RA, for 24 h prior to extraction of total RNA. Signals on Northern blots corresponding to the respective mRNA species are shown in (A). Samples were normalized for mRNA content with reference to the housekeeping gene GAPDH. Generated signals were quantified using phosphorimaging analysis and are expressed as the ratio of ALP (B) or OP (C) mRNA to GAPDH mRNA, where the result for untreated cells on plastic was given the value of 1. This experiment is representative of three similar experiments.
Figure 3
Time course of ALP, OP and PTH/PTHrP receptor (PTHR) mRNA expression in UMR106-06 cells grown on plastic or type I collagen. Cells were cultured on plastic (, ) or type I collagen (, ) in the presence (, ) or absence (, ) of 10 6 M RA, as described in Materials and Methods, for 6, 12, 18 or 24 h prior to extraction of total RNA. Signals on Northern blots corresponding to ALP, OP and PTH/PTHrP receptor mRNA species were quantified and normalized for mRNA content with reference to GAPDH mRNA levels. Data obtained were re-arranged to emphasize the level of expression of these markers over a 24 h period in the different experimental groups, compared with untreated cells cultured on plastic, for which results at 6 h were given the arbitrary value of 1. This experiment is representative of three similar experiments.
on either plastic or collagen (shown for 0·01 to 100 µM, Fig. 5 ).
To investigate a potential role for the DGEA amino acids site of the collagen molecule, experiments were designed based on the work described by Staatz et al. (1991) , in which the DGEA peptide substantially inhibited platelet adhesion to collagen, with the KDGE peptide serving as a negative control. Incubation of UMR106-06 cells on collagen in the presence of 5 mM DGEA peptide inhibited cell spreading (Fig. 6D) , compared with untreated cells on collagen (Fig. 6B) . In contrast, DGEA peptide had little effect on cell spreading with cells cultured on plastic (Fig. 6C ) compared with the untreated control (Fig. 6A) . The negative control peptide, KDGE, had no effect on cell spreading on plastic or collagen ( Fig. 6E and F respectively) . The effect of these peptides on ALP, OP and the PTH/PTHrP receptor mRNA expression was mRNA-species dependent. The 5 mM DGEA peptide eliminated the collagen-mediated increase in ALP and PTH/PTHrP receptor mRNA expression in cells cultured on plastic or collagen (Fig. 7) , although the KDGE peptide had similar activity. Both DGEA and KDGE peptides (5 mM) increased the expression of OP mRNA in cells cultured on collagen but not plastic, compared with untreated controls (Fig. 7) . Effect of GRGDTP and GRGESP peptide on collagenmediated changes in gene expression. UMR106-06 cells were incubated with GRGDTP peptide, or GRGESP peptide, at concentrations of 0·01, 1·0 or 100 µM, for 15 min prior to plating at 90% confluency onto uncoated dishes (unfilled bars) or dishes coated with 25 µg/cm 2 type I collagen (shaded bars), for 24 h prior to total RNA harvest. ALP, OP, PTH/PTHrP receptor (PTHR) and GAPDH mRNA expression were quantified by Northern blot analysis and the signals generated were quantified using phosphorimaging technology. The levels of each of the mRNA species are expressed as a ratio of GAPDH mRNA. This experiment is representative of three similar experiments.
Investigation of intracellular signalling pathways
To investigate the mechanism of the collagen-induced effects in UMR106-06 cells, we used inhibitors or activators of various intracellular signalling pathways. These were: cytochalasin D, an inhibitor of actin filament rearrangement; the phorbol ester, PMA, which activates, and chelerythrine chloride, calphostin C and H7, which inhibit, protein kinase C; okadaic acid, calyculin A and microcystin LR, which inhibit serine/threonine protein phosphatases and sodium metavanadate, which inhibits protein tyrosine phosphatases; herbimycin A and genistein, which inhibit protein tyrosine kinases; thapsigargin, which interferes with intracellular calcium storage; U73122, which inhibits phospholipase C; and indomethacin, which inhibits cyclooxygenase, as listed in Table 2 . To identify pathways differentially activated by growth of cells on collagen, it was of interest to find an agent which would specifically inhibit the collagen-mediated effects on mRNA levels in UMR106-06 cells. Several agents were found to increase or decrease expression of the PTH/ PTHrP receptor mRNA, but, with the exception of genistein and one concentration of sodium metavanadate, they did so in cells on both plastic and collagen, as summarized in Table 2 .
The protein tyrosine kinase inhibitor, genistein, but not herbimycin A, differentially decreased the collagenmediated increase in expression of mRNA for PTH/ PTHrP receptor, ALP and OP. Although high concentrations of genistein decreased mRNA expression in cells cultured on plastic as well as collagen, lower concentrations, that did not affect expression in cells cultured on plastic, were observed to dose-dependently inhibit the collagen-mediated increase (Fig. 8) . Since genistein differentially affected PTH/PTH receptor mRNA levels in cells on collagen, we examined also ALP and OP mRNA levels in genistein-treated cells. Collagen induction of these mRNA species was also inhibited by genistein (Fig. 8) .
Discussion
The ECM, in addition to its structural role, interacts with cells to provide important signals for differentiated function. Relevant to the present work is the demonstrated ability of the ECM to alter also cellular responses of osteoblasts to soluble agonists, specifically the hormone PTH. Using an osteoblast-like osteosarcoma cell line, UMR106-06 cells, we have shown here that the increased responsiveness of these cells to PTH stimulation is due to an increase in the number of cell surface PTH/PTHrP receptors. The magnitude of increase in receptor number was in close agreement with the observed changes in mRNA levels for this receptor and in the cAMP levels accumulated in response to PTH stimulation (Celic et al. 1996) . RA treatment decreased the number of receptors expressed by the cells cultured on either substrate, also consistent with previous findings of decreased receptor mRNA levels and cAMP levels in response to PTH stimulation in RA-treated cells (Celic et al. 1996) .
There are a number of reports suggesting that culture of cells on the appropriate physiological ECM results in a more differentiated cell phenotype (Blum et al. 1987 , Andrianarivo et al. 1992 , Lynch et al. 1995 . Our finding Figure 7 Effect of DGEA and KDGE peptide on collagenmediated changes in gene expression. UMR106-06 cell suspensions were incubated with DGEA or KDGE peptides, at 5 mM, for 15 min prior to plating at 90% confluency onto uncoated dishes ( ) or dishes coated with 25 µg/cm 2 type I collagen (+). RNA was harvested 24 h later. ALP, OP, PTH/PTHrP receptor (PTHR) and GAPDH mRNA levels were quantified by Northern blot analysis. The signals generated were quantified using phosphorimaging technology. The expression levels of each of the mRNA species are expressed as a ratio of GAPDH mRNA levels. This experiment is representative of three similar experiments.
of increased PTH/PTHrP receptor expression in osteoblasts cultured on type I collagen, together with reports indicating that PTH/PTHrP receptor expression is increased as a function of osteoblast maturity (Suda et al. 1995 , Bos et al. 1996 , led us to examine the expression of other osteoblast-associated gene products. We found that the expression of ALP and OP mRNA was also increased in cells cultured on type I collagen. Although UMR106-06 cells are considered to represent relatively differentiated osteoblasts, enhanced expression of these gene products in cells acutely exposed to exogenous type I collagen is consistent with the need for cellular interaction with collagen for full expression of this phenotype. RA treatment, which induces differentiation of phenotypically preosteoblastic cells (Choong et al. 1993) , had opposing effects on ALP and OP mRNA, decreasing the mRNA expression of ALP and increasing the expression of OP mRNA in cells on both substrates, consistent with previous findings with UMR106-06 cells on plastic (Zhou et al. 1991) . Downregulation of ALP mRNA expression by RA and collagen was similar to that of the PTH/PTHrP receptor (Celic et al. 1996) , with increased expression in cells cultured on type I collagen, compared with cells on plastic, and decreased expression on both substrates with RA treatment. OP, which, according to several models of osteoblast differentiation (Owen et al. 1990 ) is expressed later than ALP, differed in its response to RA treatment. RA increased the mRNA level on plastic and synergized with the effect of collagen. These results highlight the need to consider the role of physiological ECM substrates in examining cellular responses to soluble factors. Table 2 Effect of various agents, which affect intracellular signalling, on the expression of PTH/PTHrP receptor mRNA in UMR106-06 cells grown on collagen or plastic. Cells were plated onto uncoated dishes (plastic), or dishes coated with collagen, in the absence or presence of the indicated concentrations of listed agents. After 24 h, cells were examined microscopically for inhibition of cell attachment prior to isolating total RNA and performing Northern blot analysis. PTH/PTHrP receptor mRNA levels were normalized with respect to GAPDH mRNA levels. The data are representative of at least two experiments with each agent Current data suggest that cell attachment to collagen can be mediated by cell binding to several sites in the molecule. UMR106-06 cell adhesion to plastic or collagen did not appear to involve an RGD site, given the lack of effect of the GRGDTP peptide in interfering with cell attachment or collagen-mediated effects on mRNA expression in this system. The DGEA motif has been claimed to be the recognition sequence for 2 1 integrin (Staatz et al. 1991) , and has been used to block collagenmediated maturation of MC3T3-E1 osteoblast-like cells (Takeuchi et al. 1996) . The experiments described here showed that the DGEA cell-binding domain may be involved, although the results were not entirely unambiguous. In addition, since KDGE also reduced the difference in PTH/PTHrP receptor and ALP mRNA expression between the substrates, this peptide may not be an appropriate negative control in the UMR106-06 cell system, as it is in others (Staatz et al. 1991) . The results with respect to a role for the DGEA-containing site as a domain mediating the collagen-induced effects on ALP and PTH/PTHrP receptor mRNA expression are thus perhaps supportive of a recent report, in abstract, which suggests that DGEA may have direct actions on cells (McCann et al. 1996) .
Agent
Concentration
In order to further investigate the specificity of the collagen effect in UMR106-06 cells for this substrate, we examined the response of cells to chemically modified collagen. Glycation of long-lived macromolecules such as collagen, by reactive sugar moieties, is thought to perturb the interactions of these matrix molecules with their specific cellular receptors (Haitoglou et al. 1992) . When primary osteoblasts were cultured on AGE collagen, there was decreased expression of markers associated with differentiation status, such as ALP activity and osteocalcin secretion as well as decreased bone nodule formation, when compared with culture on unmodified collagen (Katayama et al. 1996) . In the present studies, AGE collagen decreased the collagen-mediated enhancement of the PTH/PTHrP receptor mRNA and OP mRNA, dose-dependently with respect to the AGE content. In contrast, ALP mRNA expression appeared to be regulated differently from the other two mRNA species and was resistant to the effects of AGE modification of collagen at all levels of glycation.
Cell binding to ECM molecules elicits a number of intracellular signalling events, although the complete signal transduction mechanisms leading to ECM-induced cell changes are not known in any cell type. We have obtained evidence that tyrosine phosphorylation is involved in the collagen-induced events seen in UMR106-06 cells. Inhibition of tyrosine phosphatase activity or of a tyrosine kinase(s), sensitive to inhibition by genistein but not herbimycin A, inhibited the collagenmediated increase in expression of the various mRNA species. Interpretation of these results is difficult and much more work will be required to delineate the intracellular signalling pathways to which these phosphorylation events belong. The differential regulation of tyrosine kinase activity by the inhibitors genistein and herbimycin A has been shown in other systems (Langholz et al. 1995) and may relate to their differing modes of action; genistein competes at the ATP-binding site (Akiyama et al. 1987) and thus has a broad range of action, whereas herbimycin Quantification of these signals was by phosphorimager analysis and results are expressed as the ratio of ALP, OP or PTHR mRNA levels to GAPDH mRNA levels, where the result for untreated cells on plastic was given the value of 1. This experiment is representative of two similar experiments.
